ARCHIVES

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI To Push “Cancer Prevention Awareness” This Month; Three RFPs Delayed For Changes

February 17, 1984

Protein Patterns May Identify Ovarian Cancer Earlier

March 29, 2002

ASCO Releases Guideline On Larynx Preservation

July 28, 2006

NI Communications Effort, Saves By Congress, Now A Major National Cancer Program Resource

August 15, 1975

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

October 25, 2013

PHS Revises Lab Animal Policies

May 10, 1985